A presumed case of Darbepoetin-induced myocardial infarction in the patient with MDS-RARS
Department
Internal Medicine
Additional Department
Oncology and Hematology
Document Type
Article
Publication Title
Clinical Case Reports
Abstract
Our case is only the 2nd such reported case of atherothrombosis from ESAs and highlights the increased risk of cardiovascular events in patients receiving erythropoietin-stimulating agents specially patients with underlying MDS where targeting a lower hemoglobin goal and optimizing other cardiovascular risk factors might be beneficial in preventing future cardiovascular mortality.
First Page
658
Last Page
660
DOI
10.1002/ccr3.2728
Volume
8
Issue
4
Publication Date
4-1-2020
PubMed ID
32274030
Recommended Citation
Zafar, A., & Kouides, P. (2020). A presumed case of Darbepoetin-induced myocardial infarction in the patient with MDS-RARS. Clinical Case Reports, 8 (4), 658-660. https://doi.org/10.1002/ccr3.2728
COinS